AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 74 of 105

75 Table 22. Antiretroviral Therapy and Statin Drug Interactions Statin Antiretroviral Drug Recommendations Protease Inhibitors Atorvastatin Atazanavir Atazanavir/ritonavir Titrate atorvastatin dose carefully and administer the lowest effective dose while monitoring for toxicities. Atazanavir/cobicistat Do not coadminister. Darunavir/cobicistat Darunavir/ritonavir Titrate atorvastatin dose carefully and administer the lowest effective dose while monitoring for toxicities. Do not exceed atorvastatin 20 mg daily. Lopinavir/ritonavir Titrate atorvastatin dose carefully and administer the lowest effective dose while monitoring for toxicities. Do not exceed atorvastatin 20 mg daily. Tipranavir/ritonavir Do not co-administer. Lovastatin All protease inhibitors Contraindicated. Pitavastatin All protease inhibitors No dose adjustment needed. Pravastatin Atazanavir/ritonavir Atazanavir/cobicistat Titrate pravastatin dose carefully while monitoring for pravastatin-related adverse events. Darunavir/cobicistat Darunavir/ritonavir Titrate pravastatin dose carefully while monitoring for pravastatin-related adverse events. Lopinavir/ritonavir No dose adjustment needed. Rosuvastatin Atazanavir/ritonavir Titrate rosuvastatin dose carefully and administer lowest effective dose while monitoring for rosuvastatin-related adverse events. Atazanavir/cobicistat Do not exceed rosuvastatin 10 mg daily. Darunavir/cobicistat Titrate rosuvastatin dose carefully and administer lowest effective dose while monitoring for rosuvastatin-related adverse events. Do not exceed rosuvastatin 20 mg daily. Darunavir/ritonavir Titrate rosuvastatin dose carefully and administer the lowest effective dose while monitoring for rosuvastatin-related adverse events. Lopinavir/ritonavir Titrate rosuvastatin dose carefully and administer the lowest effective dose. Do not exceed rosuvastatin 10 mg daily. Tipranavir/ritonavir No dose adjustment needed. Simvastatin All protease inhibitors Contraindicated.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026